Phase I trial of intravesical gemcitabine in BCG-refractory transitional cell carcinoma of the bladder

被引：0
|
作者：
Dalbagni, G
Russo, P
Sheinfeld, J
Mazumdar, M
Tong, W
Rabbani, F
Donat, SM
Herr, HW
Sogani, P
Depalma, D
Bajorin, D
机构：
来源：
JOURNAL OF UROLOGY | 2002年 / 167卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [41] Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of the bladder - Reply by the authors
    Serretta, V
    UROLOGY, 2005, 66 (05) : 1142 - 1142
  • [42] Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy
    McKiernan, James M.
    Masson, Puneet
    Murphy, Alana M.
    Goetzl, Manlio
    Olsson, Carl A.
    Petrylak, Daniel P.
    Desai, Manisha
    Benson, Mitchell C.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3075 - 3080
  • [43] A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder
    Eroglu, Zeynep
    Fruehauf, John P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (01) : 263 - 267
  • [44] A phase II study of gemcitabine and oxaliplatin in advanced transitional cell carcinoma of the bladder
    Zeynep Eroglu
    John P. Fruehauf
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 263 - 267
  • [45] A phase II trial of intravesical cabazitaxel, gemcitabine, and cisplatin (CGC) for the treatment of non-muscle invasive BCG unresponsive urothelial carcinoma of the bladder
    DeCastro, G. J.
    Stein, M.
    Abate-Shen, C.
    Miles, C.
    Gray, J.
    Joffe, B.
    Anderson, C.
    Lenis, A.
    McKiernan, J. M. M.
    ANNALS OF ONCOLOGY, 2024, 35 : S1143 - S1143
  • [46] A PHASE 1 TRIAL OF INTRAVESICAL CABAZITAXEL, GEMCITABINE, AND CISPLATIN (CGC) FOR THE TREATMENT OF NON-MUSCLE INVASIVE BCG UNRESPONSIVE UROTHELIAL CARCINOMA OF THE BLADDER
    DeCastro, G. Joel
    Anderson, Christopher
    Kates, Max
    Buckley-Matura, Bridget
    Sui, Wilson
    Lee, Shing M.
    Holder, Dara
    Virk, Renu
    Drake, Charles
    Abate-Shen, Cory
    McKiernan, James
    JOURNAL OF UROLOGY, 2019, 201 (04): : E623 - E623
  • [47] TREATMENT OF RECURRENT SUPERFICIAL TRANSITIONAL CELL-CARCINOMA OF THE BLADDER WITH INTRAVESICAL BACILLUS CALMETTE-GUERIN (BCG)
    BRENDLER, CB
    ALEXANDER, RB
    JOURNAL OF UROLOGY, 1986, 135 (04): : A284 - A284
  • [48] Disseminated Mycobacterium bovis Infection Complicating Intravesical BCG Instillation for the Treatment of Superficial Transitional Cell Carcinoma of the Bladder
    Elzein, Fatehi
    Albogami, Nada
    Saad, Mustafa
    El Tayeb, Nazik
    Alghamdi, Abdullah
    Elyamany, Ghaleb
    CLINICAL MEDICINE INSIGHTS-CASE REPORTS, 2016, 9 : 71 - 73
  • [49] Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder - Metaanalytic reevaluation
    Huncharek, M
    Kupelnick, B
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (04): : 402 - 407
  • [50] REPEATED TRANSURETHRAL RESECTION AND INTRAVESICAL BCG FOR EXTENSIVE SUPERFICIAL TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A REPORT OF 106 CASES
    Sallami, S.
    Ben rhouma, S.
    Mohamed, H.
    Nouira, Y.
    Horchani, A.
    JOURNAL OF ENDOUROLOGY, 2009, 23 : A251 - A251
12345